Skip to main content
  • PREPARE-IT 2: Icosapent Ethyl Fails to Significantly Reduce COVID Hospitalization or Death vs. Placebo

    But positive trends warrant tricky larger study, investigator says

    Prescription-strength omega-3 did not significantly reduce hospitalization or death from COVID-19 in the 2,000-outpatient decentralized PREPARE-IT 2 study, but with positive trends, strong safety profile and unexpectedly low event rates, a larger study is warranted, an investigator said.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details